Dr. Olga Oikonomidou is an Academic Consultant Medical Oncologist specializing in breast cancer and Breast Cancer Translational Research Group Leader at the Institute of Genetics and Cancer, University of Edinburgh. Other than a degree in Medicine, she holds a BSc in Human Genetics, MSc in Oncology, MRes in Immunology and a PhD in translational medicine. Her responsibilities are split between running a busy breast oncology practice and leading on a large portfolio of clinical trials and breast cancer translational studies. Dr Oikonomidou is a clinical expert for NICE and SMC and has been involved in numerous technology appraisals since 2015. She has received several prestigious grants for her clinical research projects. She is on the TMG of numerous national and international trials. She is currently the global Chief Investigator of 2 multinational multicentre clinical trials, UK Chief Investigator of 4 clinical trials and the PI for more than 50 trials. Her academic research interest is focused on prediction of biomarkers of response to treatment and clinical trials in breast cancer in all phases.